Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biolog provides industry-leading instrumentation and consumables for high-throughput phenotypic characterization of microbes/mammalian cells as well as comprehensive laboratory services for microbial identification using both traditional phenotype-based methods and modern genotypic/proteomic approaches. The company has expanded its capabilities through acquisitions to include anaerobic organism expertise and DNA sequencing-based ID. Its solutions are widely adopted in pharma QC labs, academic research centers, agri-food industries, environmental monitoring programs—enabling rapid functional insights into complex biological samples. No clinical trial results apply.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biolog.